Skip to content

A Clinical Evaluation Of Homoeopathic Medicines In The Management Of Atopic Dermatitis Using Hanifin And Rajka Criteria

A Clinical Study To Assess The Effectiveness Of Homoeopathic Medicines In The Treatment Of Atopic Dermatitis Using Hanifin And Rajka Criteria - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104160
Enrollment
34
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: individualised homoeopathic medicines: All subjects will be followed up every 2 weeks and as per the need of each case for the period of 24 weeks dose and potency will be administered o

Sponsors

Dr Savita
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to participate voluntarily and signed written informed consent. Subjects satisfying the diagnostic criteria of Hanifin and Rajka diagnostic criteria of Atopic Dermatitis. Subjects of all the age group, both the gender and irrespective of socioeconomic status.

Exclusion criteria

Exclusion criteria: Subjects with other skin diseases like dermatophytes, psoriasis, urticaria, and focal sepsis. Subjects who are on other modes of treatment for Atopic Dermatitis. Subjects with Atopic Dermatitis associated with any chronic and systemic diseases like Diabetes mellitus, Hypertension, Ischemic heart diseases, renal disease and on active treatment for other systemic diseases are excluded for studies.

Design outcomes

Primary

MeasureTime frame
improvement in SCORAD SCALE INDEXTimepoint: change in the SCORAD SCALE INDEX baseline assessed at 2 weeks and followed up to the period of 24weeks

Secondary

MeasureTime frame
improvement in SCORAD SCALE INDEXTimepoint: change in the SCORAD SCALE INDEX baseline assessed at 2 weeks & followed up to the period of 24weeks

Countries

India

Contacts

Public ContactDr Savita

B D jatti homoeopathic medical college.

drzarinaballari@gmail.com9880804839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026